Detalhe da pesquisa
1.
Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1).
Invest New Drugs
; 38(4): 1117-1128, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31667659
2.
Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2).
Invest New Drugs
; 38(4): 1096-1107, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31637669
3.
Long-term safety and anti-tumour activity of olaparib monotherapy after combination with carboplatin and paclitaxel in patients with advanced breast, ovarian or fallopian tube cancer.
Br J Cancer
; 113(3): 396-402, 2015 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26180927